Código QR (código de barras bidimensional)

Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA

Abstract Background To date, triple-negative breast cancer (TNBC) treatment options are limited because of the loss of target receptors and, as a result, are only managed with chemotherapy. What is worse is that TNBC is frequently developing resistance to chemotherapy. By using small interfering RNA...

ver descrição completa

Na minha lista:
Principais autores: Long Zhang, Chaofeng Mu, Tinghong Zhang, Dejun Yang, Chenou Wang, Qiong Chen, Lin Tang, Luhui Fan, Cong Liu, Jianliang Shen, Huaqiong Li
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2021-01-01
coleção:Journal of Nanobiotechnology
Assuntos:
RNA nanoparticles
XBP1
siRNA
TNBC
Chemoresistance
Acesso em linha:https://doi.org/10.1186/s12951-020-00758-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados